纤维蛋白原与慢性肾脏病病理的相关性

李 塘莲1, 刘海 琴*2
1、青海大学
2、青海省人民医院

摘要


近年来，关于纤维蛋白原（Fibrinogen，FIB）的研究不断深入，揭示了其在多种疾病中的多重功能和潜在的临床应用价值，它在凝血过程中起到核心作用，并且与多种病理状态有着密切的联系。纤维蛋白原在肾小球改变、足细胞凋亡和肾小管间质纤维化等病理变化中有着重要作用，因此，本文主要阐述了纤维蛋白原在肾脏疾病病理变化中的多重作用，包括凝血、炎症反应以及肾脏疾病等方面的研究进展，以便为后续研究提供理论依据。

关键词


纤维蛋白原；慢性肾脏病；足细胞；肾小管间质纤维化；血栓；炎症反应

全文:

PDF


参考


[1]Tennent GA, Brennan SO, Stangou AJ, O’Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood. 2007 Mar 1;109(5):1971-4.

[2]Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Stancanelli B, Nicocia G, Buemi M. Fibrinogen, mortality and incident cardiovascular complica-tions in end-stage renal failure. J Intern Med. 2003 Aug;254(2):132-9.

[3]Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR. Structural recognition of a novel fibrin-ogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem. 1995 Jan 13;270(2):696-9.

[4]Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001 Sep 1;167(5):2887-94.

[5]Moerloose P, Boehlen F, Neerman-Arbez M. Fibrinogen and the risk of thrombosis. Semin Thromb He-most. 2010 Feb;36(1):7-17.

[6]Martinez M, Weisel JW, Ischiropoulos H. Functional impact of oxidative posttranslational modifications on fibrinogen and fibrin clots. Free Radic Biol Med. 2013 Dec;65:411-418.

[7]Tadeusiewicz J, Nowak P. Rola modyfikacji potranslacyjnych fibrynogenu w patogenezie zakrzepicy [The role of post-translational modification of fibrinogen in the pathogenesis of thrombosis]. Pol Merkur Lekarski. 2015 Feb;38(224):107-12.

[8]Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012 Jan;34(1):43-62.

[9]Flick MJ, LaJeunesse CM, Talmage KE, Witte DP, Palumbo JS, Pinkerton MD, Thornton S, Degen JL. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest. 2007 Nov;117(11):3224-35.

[10]Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Gröne HJ, Krämer BK, Alpers CE. TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol. 2008 Apr;19(4):704-13.

[11]Ma S, Qiu Y, Zhang C. Cytoskeleton Rearrangement in Podocytopathies: An Update. Int J Mol Sci. 2024 Jan 4;25(1):647.

[12]Wang H, Zheng C, Xu X, Zhao Y, Lu Y, Liu Z. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients. Nephrology (Carlton). 2018 May;23(5):418-429.

[13]Motojima M, Matsusaka T, Kon V, Ichikawa I. Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Nephron Exp Nephrol. 2010;114(2):e39-47.

[14]张虹.血浆纤维蛋白原与特发性膜性肾病的相关性研究[D].苏州大学，2019.

[15]唐露，司晶，徐寒梅.肾纤维化相关信号通路研究进展[J].药学进展，2021，45（07）：532-538.

[16]Grande MT, Sánchez-Laorden B, López-Blau C, De Frutos CA, Boutet A, Arévalo M, Rowe RG, Weiss SJ, López-Novoa JM, Nieto MA. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med. 2015 Sep;21(9):989-97. DOI: 10.1038/nm.3901. Epub 2015 Aug 3. Erratum in: Nat Med. 2016 Feb;22(2):217.

[17]Campbell KN, Tumlin JA. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glo-merulosclerosis. Am J Nephrol. 2018;47 Suppl 1(Suppl 1):14-29.

[18]Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007 Mar;22(3):350-4.

[19]Shabaka A, Tato Ribera A, Fernández-Juárez G. Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective. Nephron. 2020;144(9):413-427.

[20]徐丽辰，李贵森.局灶节段性肾小球硬化发病机制及治疗进展[J].内科理论与实践，2023，18（05）：363-367.

[21]Bukosza EN, Kratochwill K, Kornauth C, Schachner H, Aufricht C, Gebeshuber CA. Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS. PLoS One. 2020 Apr 17;15(4):e0231898.

[22]JONES DB. Nephrotic glomerulonephritis. Am J Pathol. 1957 Mar-Apr;33(2):313-29.

[23]郭晓琴.凝血相关指标与膜性肾病预后的临床研究[D].山西：山西医科大学，2021，1-7.

[24]龚丽苏.凝血相关指标在原发性膜性肾病中的临床意义[D].吉林大学，2022.

[25]Katafuchi R, Nagae H, Masutani K, Tsuruya K, Mitsuiki K. Comprehensive evaluation of the signifi-cance of immunofluorescent findings on clinicopathological features in IgA nephropathy. Clin Exp Nephrol. 2019 Feb;23(2):169-181.

[26]王惠英，严海燕，韩艳平等.IgA肾病患者肾小球内纤维蛋白原沉积的意义[J].中国热带医学，2008，8（11）：1960-1962.

[27]王凤英，李晓忠，王兴东，等.肾小球内纤维蛋白原沉积在儿童过敏性紫癜性肾炎中的意义[J].临床儿科杂志，2018，36（03）：182-187.

[28]Hoffmann D, Bijol V, Krishnamoorthy A, Gonzalez VR, Frendl G, Zhang Q, Goering PL, Brown RP, Waikar SS, Vaidya VS. Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a transla-tional biomarker for acute kidney injury. Am J Pathol. 2012 Sep;181(3):818-28.

[29]Krishnamoorthy A, Ajay AK, Hoffmann D, Kim TM, Ramirez V, Campanholle G, Bobadilla NA, Wai-kar SS, Vaidya VS. Fibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood. 2011 Aug 18;118(7):1934-42.

[30]Xia W, Li C, Yao X, Chen Y, Zhang Y, Hu H. Prognostic value of fibrinogen to albumin ratios among critically ill patients with acute kidney injury. Intern Emerg Med. 2022 Jun;17(4):1023-1031.

[31]Jahangirifard A, Ahmadi ZH, Naghashzadeh F, Sharif-Kashani B, Rashid-Farokhi F, Afshar A, Yamini-Sharif R, Rezaei Y. Prophylactic Fibrinogen Decreases Postoperative Bleeding but Not Acute Kidney Injury in Patients Undergoing Heart Transplantation. Clin Appl Thromb Hemost. 2018 Sep;24(6):998-1004.


Refbacks

  • 当前没有refback。